A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors
暂无分享,去创建一个
Suzanne F. Jones | H. Burris | S. Boerner | Daphne D Williams | L. Pandite | S. Kathman | P. Lorusso | P. Ho | J. Hodge | P. LoRusso | Daphne D. Williams | Steven J. Kathman | Scott A. Boerner